[1]
A. Egeberg, “Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3”, Acta Derm Venereol, vol. 102, p. adv00787, Oct. 2022.